Clinicians and researchers can use the new “Quality of Life in People with Hearing Loss Questionnaire (HL-QoL)” to assess how hearing loss and treatment affect an individual’s quality of life. As the first validated questionnaire based on the WHO’s international classification of functioning, disability, and health, it is designed to assess hearing outcomes while providing a holistic perspective.

Prof. Dr. Philippe Lefèbvre and Prof. Dr. Joachim Müller share their experiences leading the feasibility study on MED-EL’s Totally Implantable Cochlear Implant (TICI), breakthrough technology that integrates all cochlear implant components—audio processor, microphone, and battery—into one device under the skin.

While the cause of Meniere’s disease (MD) remains an enigma, a review of recent literature provides some valuable findings to keep in mind when considering cochlear implant candidacy and care for patients with Meniere’s disease.

Understanding music is a complex process. MED-EL's cochlear implant technology makes it possible for users to perceive and appreciate music.

Cochlear implantation is internationally recognized as the standard of care for patients with severe-to-profound hearing loss , with bilateral implantation regarded as the gold standard. However, despite a well-established body of research highlighting the cost-effectiveness of bilateral cochlear implantation and improved quality of life outcomes, it is believed that just 4.2% of people who are